American Regent secures rare PI win in Hatch-Waxman dispute

Pharma giant wins preliminary injunction ‘in public interest’ regarding a generic of its Selenious Acid Injection | Judge finds infringement by pharma company Eugia of two Orange Book patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI

14 May 2026 Isomorphic Labs said the funding round, led by venture firm Thrive Capital, would be used to further its drug design engine and support hiring targets.

Americas

10x Genomics settles suit with rival and targets DNA sequencing startup

12 May 2026 The dominant player in the spatial biology market has sued a San Diego-based life sciences company over its genetic analysis technology, as another lawsuit in its patent litigation campaign approaches conclusion.

Americas

Brussels under scrutiny for IP policy as US flags risks to innovation

1 May 2026 The Office of the US Trade Representative has placed the EU on its Watch List, outlining concerns about pharma legislation, GIs and digital copyright.

More features

WATCH: Kymera Therapeutics’ Sylvia Yip on in-house leadership

UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI

Blank Rome adds to growing team with patent agent from MBHB

BMS signs $15.2bn deal with China’s top pharma company

Medtech company sues over seven patents for incontinence products

10x Genomics settles suit with rival and targets DNA sequencing startup

Trade secrets, AI and the new scrutiny of big damages awards

WATCH: Interview with Mythili Markowski, director at Regeneron

American Regent secures rare PI win in Hatch-Waxman dispute

More on this story

Editor's picks

Editor's picks

More features